Stereotaxis, Inc. (STXS) Stock

Stereotaxis, Inc. (STXS) is a Healthcare stock trading at $1.45 (as of 2026-08-20), with a market capitalization of $141.23M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Stereotaxis, Inc. develops and sells robotic magnetic navigation systems, related imaging hardware, and procedure information solutions used in interventional labs. Its offerings include RMN systems for image-guided catheter and guidewire navigation, real-time networking software to manage and share procedures, and associated disposables and accessories.

Understand Stereotaxis, Inc.: how it makes money

Stereotaxis designs, manufactures, and markets robotic magnetic navigation systems and related instruments and information systems for interventional labs, making money by selling its Systems and by generating ongoing Revenue from Disposables, Service and Accessories tied to those procedures.

The companys profit model is built around an installed-base dynamic, where initial Systems sales can be complemented by ongoing recurring Revenue from Disposables, Service and Accessories (captured in its Recurring Revenue metric).

Revenue by segment (latest quarter)
Systems$0.0B
DSA$0.0B

Business quality (Weak): Readable business model and operating KPI are provided, but the latest quarter shows 0.0B revenue across both reported segments, so results and segment trends may reflect timing rather than underlying demand.

Bull case

  • Gross margin was 60.3% in the latest reported quarter: This suggests the core product and service mix can support positive gross profitability even when operating income is not achieved.
  • Recurring Revenue was reported at 0.01 USD_B: This indicates at least some ongoing monetization beyond one-time Systems revenue.

Bear case

  • Operating margin was -95.1% in the latest reported quarter: This reflects substantial operating losses, which can pressure liquidity and limit financial flexibility.
  • Revenue from both Systems and Revenue from Disposables, Service and Accessories was 0.0 USD_B in the latest reported quarter: That makes it difficult to assess current commercial momentum based on segment revenue alone.
Valuation — source: SEC EDGAR (first-party)
Price$1.45
Market Cap$141.23M
Price / Book9.84
Price / Sales4.53
FCF Yield-8.1%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$32.38M
Net Margin-66.8%
Revenue Growth (YoY)-15.8%
EPS Growth (YoY)-14.3%
Financial Health — source: SEC EDGAR
Altman Z-Score-13.97 (distress)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderDAFNA Capital Management LLC ($25.17M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEODavid Leo Fischel
Employees139
CountryUS
IPO Date2004-08-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • CapsoVision, Inc. (CV)
  • FONAR Corporation (FONR)
  • Vivani Medical, Inc. (VANI)
  • electroCore, Inc. (ECOR)
  • Hyperfine, Inc. (HYPR)
  • Streamex Corp. (STEX)
  • Outset Medical, Inc. (OM)
  • NeurAxis, Inc. (NRXS)
STXS earnings history · STXS institutional & insider holders · STXS KPIs & operating metrics · STXS financials · STXS investor presentations & press releases · STXS SEC filings · STXS peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.